On the public citation graph

Patient-reported outcomes in randomised controlled trials of gynaecological cancers: Investigating methodological quality and impact on clinical decision-making

0 signed · 85 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.2013.879openalex-snapshot
Reporting of Patient-Reported Outcomes in Randomized Trials
inferredcites →https://doi.org/10.1002/cncr.11065openalex-snapshot
Health related quality of life in prostate carcinoma patients
inferredcites →https://doi.org/10.1002/ijc.25516openalex-snapshot
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
inferredcites →https://doi.org/10.1002/pon.1426openalex-snapshot
Quality of life and sexual functioning after cervical cancer treatment: a long‐term follow‐up study
inferredcites →https://doi.org/10.1007/s11136-012-0252-1openalex-snapshot
Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards
inferredcites →https://doi.org/10.1016/j.eururo.2013.10.017openalex-snapshot
Patient-reported Outcomes in Randomised Controlled Trials of Prostate Cancer: Methodological Quality and Impact on Clinical Decision Making
inferredcites →https://doi.org/10.1016/j.jclinepi.2009.06.005openalex-snapshot
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
inferredcites →https://doi.org/10.1016/j.ygyno.2006.03.050openalex-snapshot
A critical review of patient-rated quality of life studies of long-term survivors of cervical cancer
inferredcites →https://doi.org/10.1016/j.ygyno.2009.06.021openalex-snapshot
A Gynecologic Oncology Group Study of serum CA-125 levels in patients with stage III optimally debulked ovarian cancer treated with intraperitoneal compared to intravenous chemotherapy: An analysis of patients enrolled in GOG 172
inferredcites →https://doi.org/10.1016/j.ygyno.2011.04.019openalex-snapshot
Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: Analysis from the GCIG CALYPSO relapsing ovarian cancer trial
inferredcites →https://doi.org/10.1016/j.ygyno.2011.11.032openalex-snapshot
The association between quality of life domains and overall survival in ovarian cancer patients during adjuvant chemotherapy: A Gynecologic Oncology Group Study
inferredcites →https://doi.org/10.1016/j.ygyno.2013.08.014openalex-snapshot
Quality of life of advanced ovarian cancer patients in the randomized phase III study comparing primary debulking surgery versus neo-adjuvant chemotherapy
inferredcites →https://doi.org/10.1016/s0140-6736(00)02139-5openalex-snapshot
Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial
inferredcites →https://doi.org/10.1016/s1470-2045(02)00876-8openalex-snapshot
Quality of life in patients undergoing systemic therapy for advanced breast cancer
inferredcites →https://doi.org/10.1038/bjc.2011.593openalex-snapshot
CA-125 can be part of the tumour evaluation criteria in ovarian cancer trials: experience of the GCIG CALYPSO trial
inferredcites →https://doi.org/10.1038/sj.bjc.6605050openalex-snapshot
The impact of radiotherapy late effects on quality of life in gynaecological cancer patients
inferredcites →https://doi.org/10.1056/nejm199905063401802openalex-snapshot
Vaginal Changes and Sexuality in Women with a History of Cervical Cancer
inferredcites →https://doi.org/10.1056/nejmoa052985openalex-snapshot
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
inferredcites →https://doi.org/10.1056/nejmoa0908806openalex-snapshot
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
inferredcites →https://doi.org/10.1093/annonc/mdr001openalex-snapshot
Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study
inferredcites →https://doi.org/10.1093/annonc/mdr441openalex-snapshot
Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial
inferredcites →https://doi.org/10.1093/annonc/mdr583openalex-snapshot
Health-related quality of life in recurrent platinum-sensitive ovarian cancer—results from the CALYPSO trial
inferredcites →https://doi.org/10.1093/jncimonographs/lgm002openalex-snapshot
Translating the Science of Patient-Reported Outcomes Assessment Into Clinical Practice
inferredcites →https://doi.org/10.1111/j.1048-891x.2004.14524.xopenalex-snapshot
Vulvar cancer patients' quality of life: a qualitative assessment
inferredcites →https://doi.org/10.1136/bmj.b2535openalex-snapshot
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
inferredcites →https://doi.org/10.1136/bmj.d5928openalex-snapshot
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
inferredcites →https://doi.org/10.1177/009286150203600127openalex-snapshot
Patient-Reported Outcomes: The Example of Health-Related Quality of Life—a European Guidance Document for the Improved Integration of Health-Related Quality of Life Assessment in the Drug Regulatory Process
inferredcites →https://doi.org/10.1200/jco.2006.07.3494openalex-snapshot
Health-Related Quality of Life During and After Intraperitoneal Versus Intravenous Chemotherapy for Optimally Debulked Ovarian Cancer: A Gynecologic Oncology Group Study
inferredcites →https://doi.org/10.1200/jco.2009.22.3248openalex-snapshot
Laparoscopy Compared With Laparotomy for Comprehensive Surgical Staging of Uterine Cancer: Gynecologic Oncology Group Study LAP2
inferredcites →https://doi.org/10.1200/jco.2009.22.3529openalex-snapshot
Quality of Life of Patients With Endometrial Cancer Undergoing Laparoscopic International Federation of Gynecology and Obstetrics Staging Compared With Laparotomy: A Gynecologic Oncology Group Study
inferredcites →https://doi.org/10.1200/jco.2009.25.7519openalex-snapshot
Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse
inferredcites →https://doi.org/10.1200/jco.2010.32.3683openalex-snapshot
Health-Related Quality of Life in Non–Small-Cell Lung Cancer: An Update of a Systematic Review on Methodologic Issues in Randomized Controlled Trials
inferredcites →https://doi.org/10.1200/jco.2011.38.8645openalex-snapshot
Recurrence and Survival After Random Assignment to Laparoscopy Versus Laparotomy for Comprehensive Surgical Staging of Uterine Cancer: Gynecologic Oncology Group LAP2 Study
inferredcites →https://doi.org/10.1200/jco.2012.42.5967openalex-snapshot
Recommendations for Incorporating Patient-Reported Outcomes Into Clinical Comparative Effectiveness Research in Adult Oncology
inferredcites →https://doi.org/10.1371/journal.pmed.1000097openalex-snapshot
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4631495openalex-extracted
15 Years of Patient-Reported Outcomes in Clinical Trials Leading to Gu Cancer Drug Approvals: A Focus on the Quality of Data Reporting and Analysis
inferred← citeshttps://doi.org/10.1002/cncr.29489openalex-snapshot
Quality of patient‐reported outcome reporting across cancer randomized controlled trials according to the CONSORT patient‐reported outcome extension: A pooled analysis of 557 trials
inferred← citeshttps://doi.org/10.1002/pon.70152openalex-snapshot
The Reporting Completeness of Patient‐Reported Outcome in Randomized Controlled Trials of Non‐Small Cell Lung Cancer Could Be Improved: A Systematic Review
inferred← citeshttps://doi.org/10.1007/978-3-319-32364-0_8openalex-snapshot
Oral Health Issues and Quality of Life Among Pediatric Cancer Survivors
inferred← citeshttps://doi.org/10.1007/s11136-015-1113-5openalex-snapshot
Evaluation of point-of-care PRO assessment in clinic settings: integration, parallel-forms reliability, and patient acceptability of electronic QOL measures during clinic visits
inferred← citeshttps://doi.org/10.1007/s11136-017-1508-6openalex-snapshot
Preliminary evidence on the uptake, use and benefits of the CONSORT-PRO extension
inferred← citeshttps://doi.org/10.1007/s11136-021-02946-7openalex-snapshot
Comparing the use of patient-reported outcomes in clinical studies in Europe in 2008 and 2018: a literature review
inferred← citeshttps://doi.org/10.1016/b978-0-12-803302-9.00006-3openalex-snapshot
Immunotherapy for Transforming Advanced Cancer into a Chronic Disease
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2015.07.012openalex-snapshot
Health-related quality of life and symptom assessment in randomized controlled trials of patients with leukemia and myelodysplastic syndromes: What have we learned?
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2017.02.012openalex-snapshot
Quality of reporting in oncology studies: A systematic analysis of literature reviews and prospects
inferred← citeshttps://doi.org/10.1016/j.diabres.2022.109879openalex-snapshot
Quality of patient-reported outcome reporting in trials of diabetes in pregnancy: A systematic review
inferred← citeshttps://doi.org/10.1016/j.eclinm.2023.102413openalex-snapshot
15 years of patient-reported outcomes in clinical trials leading to GU cancer drug approvals: a systematic review on the quality of data reporting and analysis
inferred← citeshttps://doi.org/10.1016/j.ejca.2015.12.025openalex-snapshot
Patient-reported outcomes in head and neck and thyroid cancer randomised controlled trials: A systematic review of completeness of reporting and impact on interpretation
inferred← citeshttps://doi.org/10.1016/j.ejca.2017.03.019openalex-snapshot
Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: Recommendations on incorporating patient-reported outcomes in clinical trials in epithelial ovarian cancer
inferred← citeshttps://doi.org/10.1016/j.jamcollsurg.2017.10.023openalex-snapshot
Randomized Controlled Trials Evaluating Patient-Reported Outcomes after Cholecystectomy: A Systematic Review
inferred← citeshttps://doi.org/10.1016/j.jogc.2019.09.011openalex-snapshot
Obesity in Pregnancy – Patient-Reported Outcomes in Qualitative Research: A Systematic Review
inferred← citeshttps://doi.org/10.1016/j.msard.2022.103819openalex-snapshot
Incomplete reporting of patient-reported outcomes in multiple sclerosis: A meta-epidemiological study of randomized controlled trials
inferred← citeshttps://doi.org/10.1016/j.urolonc.2015.04.002openalex-snapshot
Quality of life and symptom assessment in randomized clinical trials of bladder cancer: A systematic review
inferred← citeshttps://doi.org/10.1016/j.ygyno.2014.11.071openalex-snapshot
Use of patient-reported outcomes to measure symptoms and health related quality of life in the clinic
inferred← citeshttps://doi.org/10.1016/j.ygyno.2015.10.024openalex-snapshot
Health-related quality of life after robotic-assisted laparoscopic hysterectomy for women with endometrial cancer — A prospective cohort study
inferred← citeshttps://doi.org/10.1016/j.ygyno.2017.11.011openalex-snapshot
The use of patient-reported outcome tools in Gynecologic Oncology research, clinical practice, and value-based care
inferred← citeshttps://doi.org/10.1016/j.ygyno.2021.10.084openalex-snapshot
Initial findings from a prospective, large scale patient reported outcomes program in patients with gynecologic malignancy
inferred← citeshttps://doi.org/10.1016/j.ygyno.2026.05.032openalex-snapshot
Psychometric evaluation of the NFOSI-18 disease related symptoms – Physical, NFOSI-18 Total, and FACT GP5 in the recurrent ovarian cancer phase III study GY004
inferred← citeshttps://doi.org/10.1016/s1470-2045(19)30335-3openalex-snapshot
US Food and Drug Administration review of statistical analysis of patient-reported outcomes in lung cancer clinical trials approved between January, 2008, and December, 2017
inferred← citeshttps://doi.org/10.1093/annonc/mdw080openalex-snapshot
Patient-reported outcomes (PRO) in ovarian cancer clinical trials—lost opportunities and lessons learned
inferred← citeshttps://doi.org/10.1093/jnci/djz038openalex-snapshot
Systematic Evaluation of Patient-Reported Outcome Protocol Content and Reporting in Cancer Trials
inferred← citeshttps://doi.org/10.1136/bmjebm-2021-111876openalex-snapshot
Reporting of patient-reported outcomes in trials on alcohol use disorder: a meta-epidemiological study
inferred← citeshttps://doi.org/10.1136/bmjspcare-2019-001902openalex-snapshot
Inclusion of older patients with cancer in randomised controlled trials with patient-reported outcomes: a systematic review
inferred← citeshttps://doi.org/10.1177/17539447241303724openalex-snapshot
Assessing the completeness of patient-reported outcomes reporting in congestive heart failure clinical trials
inferred← citeshttps://doi.org/10.1177/1945892420930967openalex-snapshot
Patient-Reported Outcomes in Sinonasal and Skull Base Malignancy: An Assessment of Study Quality and Clinical Relevance
inferred← citeshttps://doi.org/10.1186/s12955-016-0527-2openalex-snapshot
Systematic review reveals lack of quality in reporting health-related quality of life in patients with gastroenteropancreatic neuroendocrine tumours
inferred← citeshttps://doi.org/10.1186/s12955-019-1220-zopenalex-snapshot
The impact of patient-reported outcome (PRO) data from clinical trials: a systematic review and critical analysis
inferred← citeshttps://doi.org/10.1186/s40900-018-0109-zopenalex-snapshot
Taking patient reported outcomes centre stage in cancer research – why has it taken so long?
inferred← citeshttps://doi.org/10.1186/s41687-020-00219-4openalex-snapshot
The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders
inferred← citeshttps://doi.org/10.1371/journal.pone.0144658openalex-snapshot
Management of Patient-Reported Outcome (PRO) Alerts in Clinical Trials: A Cross Sectional Survey.
inferred← citeshttps://doi.org/10.1634/theoncologist.2017-0297openalex-snapshot
A Systematic Review of Health-Related Quality of Life Reporting in Ovarian Cancer Phase III Clinical Trials: Room to Improve
inferred← citeshttps://doi.org/10.19156/cbn.2017.0049openalex-snapshot
Patient-reported outcomes in ovarian cancer
inferred← citeshttps://doi.org/10.2147/prom.s156279openalex-snapshot
The importance of patient-reported outcomes in clinical trials and strategies for future optimization
inferred← citeshttps://doi.org/10.2196/16128openalex-snapshot
Implementation of an Electronic Patient-Reported Outcome App for Health-Related Quality of Life in Breast Cancer Patients: Evaluation and Acceptability Analysis in a Two-Center Prospective Trial
inferred← citeshttps://doi.org/10.2196/26574openalex-snapshot
Selecting a Subset Based on the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events for Patient-Reported Symptom Monitoring in Lung Cancer Treatment: Mixed Methods Study
inferred← citeshttps://doi.org/10.2217/cer-2018-0092openalex-snapshot
Clinician-reported symptomatic adverse events in cancer trials: are they concordant with patient-reported outcomes?
inferred← citeshttps://doi.org/10.3390/cancers12113296openalex-snapshot
Measuring Quality of Life in Ovarian Cancer Clinical Trials—Can We Improve Objectivity and Cross Trial Comparisons?
inferred← citeshttps://doi.org/10.4143/crt.2017.361openalex-snapshot
Development and Validation of Ovarian Symptom Index-18 and Neurotoxicity-4 for Korean Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
inferred← citeshttps://doi.org/10.6084/m9.figshare.12607244openalex-snapshot
Additional file 1 of The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders
inferred← citeshttps://doi.org/10.6084/m9.figshare.12607247openalex-snapshot
Additional file 2 of The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders
inferred← citeshttps://doi.org/10.6084/m9.figshare.12607250openalex-snapshot
Additional file 3 of The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders
inferred← citeshttps://doi.org/10.6084/m9.figshare.12607253openalex-snapshot
Additional file 4 of The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders
inferred← citeshttps://doi.org/10.6084/m9.figshare.12607256openalex-snapshot
Additional file 5 of The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders
inferred← citeshttps://doi.org/10.70675/bbd245c8z3efdz4412z99a9z55363bd4c4bfopenalex-snapshot
Méthodologie et qualité du reporting des études en oncologie (essais de phase II et études observationnelles)
inferred← citeshttps://doi.org/10.7759/cureus.95017openalex-snapshot
Effects of Yoga Interventions on Health Outcomes in Women With Gynecological Cancers: A Systematic Review of Randomised Controlled Trials
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.